Provided by Tiger Trade Technology Pte. Ltd.

ADMA Biologics

9.55
-0.2900-2.95%
Post-market: 9.54-0.0100-0.10%17:19 EDT
Volume:1.96M
Turnover:18.90M
Market Cap:2.14B
PE:13.64
High:9.91
Open:9.80
Low:9.54
Close:9.84
52wk High:20.46
52wk Low:7.21
Shares:223.98M
Float Shares:210.51M
Volume Ratio:1.06
T/O Rate:0.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7004
EPS(LYR):0.6000
ROE:41.90%
ROA:21.78%
PB:5.24
PE(LYR):15.92

Loading ...

ADMA Biologics Faces Federal Securities Lawsuit Over Alleged Channel Stuffing Scheme and Undisclosed Related Party Transactions

TIPRANKS
·
Jun 16

Nutrien, CAVA, Cracker Barrel, ADMA, CRISPR Trending With Analysts

TIPRANKS
·
Jun 13

ADMA Biologics Faces Securities Fraud Class Action, Investors Sustain Heavy Losses

Deep News
·
Jun 12

Why ADMA Biologics (ADMA) Is Up 9.3% After Securities Fraud Class Actions Over ASCENIV Sales Practices

Simply Wall St.
·
Jun 11

ADMA Biologics Shareholders Back Board, Auditor and Pay

TIPRANKS
·
Jun 03

ADMA Biologics holds annual shareholder meeting

Reuters
·
Jun 03

Insider Makes Bold Move With Fresh ADMA Biologics Buy

TIPRANKS
·
May 29

ADMA Biologics director Jerrold B. Grossman acquires 6,400 common shares worth $50,624

Reuters
·
May 29

ADMA Biologics director Jerrold B. Grossman acquires USD 100,125 common shares

Reuters
·
May 14

A Look At ADMA Biologics (ADMA) Valuation After Short Seller Allegations And Legal Investigations

Simply Wall St.
·
May 13

ADMA Biologics director Jerrold B Grossman acquires $100,125 in common shares

Reuters
·
May 13

Stock Track | ADMA Biologics Soars 5.31% Intraday on Strong Q1 Earnings Fueled by ASCENIV

Stock Track
·
May 08

ADMA Biologics Earnings Call: ASCENIV Fuels Profits

TIPRANKS
·
May 08

ADMA Biologics Is Maintained at Outperform by Mizuho

Dow Jones
·
May 07

ADMA Biologics Inc : Mizuho Cuts Target Price to $20 From $24

THOMSON REUTERS
·
May 07

Stock Track | ADMA Biologics Plunges 21.63% in Pre-market on Earnings Miss and Withdrawn Long-Term Guidance

Stock Track
·
May 07

Stock Track | ADMA Biologics Plunges 24% Post-Market on Earnings Miss and Withdrawn Long-Term Guidance

Stock Track
·
May 07

Stock Track | ADMA Biologics Plunges 26.88% After-Hours on Earnings Miss and Withdrawn Long-Term Guidance

Stock Track
·
May 07

ADMA Biologics withdraws long-term outlook on competitive dynamics in PDT & IG market

Reuters
·
May 07

ADMA Biologics 1Q26 adjusted net income rises 22% to $40.7 million; revenue flat at $114.5 million

Reuters
·
May 07